Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 12-2012 | |
| Operating Expenses | 2,989 | 0 |
| Operating Income | -2,989 | N/A |
| Interest Expense | 107 | 0 |
| Other Income | 6 | 0 |
| Pre-tax Income | -3,090 | 0 |
| Net Income Continuous | -3,090 | N/A |
| Net Income | $-3,090 | $N/A |
| EPS Basic Total Ops | -1.19 | N/A |
| EPS Basic Continuous Ops | -1.19 | N/A |
| EPS Diluted Total Ops | -1.19 | N/A |
| EPS Diluted Continuous Ops | -1.19 | N/A |
| EBITDA(a) | $-2,989 | $N/A |